medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2009, Number 09

<< Back

Ginecol Obstet Mex 2009; 77 (09)

Clinical practice guidelines. Study of climacteric and menopause

Vázquez MVJE, Morfín MJ, Motta ME

Language: Spanish
References: 58
Page: 253-276
PDF size: 268.63 Kb.


ABSTRACT

No abstract


REFERENCES

  1. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. AACE diabetes mellitus guidelines. Screening and diagnosis. Endocr Pract 2007;13(Supp. 1):10-2. Nivel III.

  2. Expert panel on Detection, evaluation and treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Eductation Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAM A 2001;285:2486-97.

  3. Primary and preventive care: periodic assessments. ACOG Committee Opinion 292. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003;102:1117-24.

  4. Delgado A, Sanchez MC, Galindo I, Perez C, Duque MJ. Women’s attitudes to menopause and predictive variables. Aten Primaria 2001;27:3-11.

  5. Blumel JE, Hernandez JA, Motta E. Age at menopause in Latin America. Menopause 2006;13:706-12.

  6. Hernández-Laos E. Desarrollo demográfico y económico de México. Consejo Nacional de Población 2006. [en línea]. Dirección URL: .

  7. US Consensus Bureau. lnternational Data Base (lOB). [en línea]. Dirección URL: .

  8. Instituto Nacional de Estadística, Geografía e Informática. Censo General de Población y Vivienda 2000. [en línea]. Dirección URL: .

  9. Consejo Nacional de Población. Salud Reproductiva. [en línea]. Dirección URL:

  10. Stearns V, Ullmer L, Lopez JF, Smith Y, et al. Hot flushes. Lancet 2002;360:1851-61.

  11. Williams RE, Kalilani L, Bibenedetti DB, Zhou X, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric 2008;11:32-43.

  12. Samsoie G. The menopause revisited. Int J Gynecol Obstet 1995;51:1-13.

  13. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999;180:S312-316.

  14. Gold B, Block G, Crawford S, Lachance L, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women’s Health Across the Nation. Am J Epidemiol 2004;159:1189-99.

  15. Society of Obstetricians and Gynecologists of Canada. Canadian Consensus Conference on Menopause, 2006. Update JOGC 2006:28:S7

  16. Grupo de trabajo de menopausia y postmenopausia. Guía de práctica clínica sobre la menopausia y postmenopausia. Barcelona: Sociedad Española de Ginecología y Obstetricia, Asociación Española para el Estudio de la Menopausia, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano, 2004.

  17. Burger HG, Dudley EC, Hopper JL, Shelley JM, et al. The endocrinology of the menopausal transition: a cross sectional study of a population based sample. J Clin Endocrinol Metab 1995;80:35-7.

  18. Shumaker SA, Legault C, Rapp SR, Thal L, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study: A Randomized Controlled Trial. JAMA 2003;289:2651- 62.

  19. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2663.

  20. McCoy NL. Methodological problems in the study of sexuality and the menopause. Maturitas 1998;29:51-60.

  21. Organización Mundial de la Salud. [en línea]. Dirección URL: .

  22. Utian WH: Quality of life (QOL) in menopause. Maturitas 2007;57:100-2.

  23. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chronic Dis 1978;31:201-306.

  24. Lasses y Ojeda LA, Gutierrez JL, Salazar E. Dyslipidemia in the elderly. Arch Cardiol Mex 2004;74:315-26.

  25. Chavez-Domínguez R, Ramírez-Hernandez JA, Casanova-Garces JM. Coronary heart disease in Mexico and the clinical epidemiological and preventive relevance. Arch Cardiol Mex 2003;73:1 05-14.

  26. Rodriguez T, Malvezzi M, Chatenoud L, Bosetti C, et al. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart 2006;92:453-60.

  27. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.

  28. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative Investigators. JAMA 2002;288:321-33.

  29. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. AACE diabetes mellitus guidelines. Screening and diagnosis. Endocr Pract 2007;13(Suppl. 1):10-12.

  30. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl. 1):s5-s20.

  31. Chobanian AV, Bakris GL, Black HR, Cushman WC, et al. The seventh of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560-72.

  32. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.

  33. Organización Mundial de la Salud. Global Database on Body Mass Index. [en línea]. Dirección URL: .

  34. Poirier P, Giles TD, Bray GA, Hong Y, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.

  35. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report 1998. [en línea]. Dirección URL: .

  36. American Heart Association. Metabolic syndrome. [en línea]. Dirección URL: .

  37. Alberti KGM. Zimmet P. Shaw J. Metabolic syndrome- a new world-wide definition. A consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.

  38. Alberti KGM. Zimmet P. Shaw J. Metabolic syndrome- a new world-wide definition. A consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.

  39. Burger HD, Dudley EC, Hopper JL, Gromee N, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84:4025-30.

  40. Rannevik G, Jeppsson S, Johnell O, Bjerre B, et al. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995;21:1 03.

  41. Soules MR, Sherman S, Parrott E, Rebar R, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001 ;4:267. Nivelili.

  42. Klein NA, Battaglia DE, Woodruff TK, Padmanabhan V, et al. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (lGFBP-2), IGFBP-3, and vascular endothelial growt factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metab 2000;85:4520-5.

  43. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2382-8.

  44. Institute for Clinical Systems Improvement (ICSI) Menopause and hormone therapy (HT): collaborative decision-making and management. 2006. [en línea]. Dirección URL: .

  45. Poutignat N. Value of measuring FSH and LH levels in women aged 45 or over. [en línea]. Dirección URL: .

  46. Ladenson PW, Singer PA, Ain KB, Bagchi N, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000;160:1573-5.

  47. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. AACE diabetes mellitus guidelines. Screening and diagnosis. Endocr Pract 2007;13(Suppl. 1):10-12.

  48. Expert Committee on the DiagnOSis and Classification of Diabetes Mellitus. Report of the expert committee on diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(suppl. 1):s5-s20.

  49. Primary and preventive care: periodic assessments. ACOG Committee Opinion 292. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003:102-1117-24.

  50. Expert panel on Detection, evaluation and treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Eductation Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.

  51. Primary and preventive care: periodic assessments. ACOG Committee Opinion 292. American College of Obstetricians and Gynecologists. Obstet GynecoI2003;102:1117-24.

  52. SSA: Modificación a La Norma Oficial Mexicana Nom-014-SSA-1994, para la Prevención, Detección, Diagnóstico, Tratamiento, Control y Vigilancia Epidemiológica del Cáncer Cervicouterino.

  53. American Cancer Society. Cancer facts y figures 2003. Atlanta:ACS;2003.

  54. Gull B, Karlsson B, Milsom I, Granberg S. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 2003;188:401-8.

  55. Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002;99:663-70.

  56. Schnatz PF. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006;107:702.

  57. Norma Oficial Mexicana NOM-035-SSA2-2002, Prevención y control de enfermedades en la perimenopausia y postmenopausia de la mujer. Criterios para brindar la atención médica. Diario Oficial, jueves 18 de Septiembre de 2003.

  58. Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. Climacteric 2001;4:267-72.




2020     |     www.medigraphic.com